Healthcare_Diksha

  Automated Hospital Beds Market Overview The global automated hospital beds market is reported to grow at a steady and decent pace as per the recently released report by Market Research Future (MRFR). The market is expected to jump from its 2022 valuation of USD 1,590.1 million to reach a valuation of 2,553.4 million by 2030. The global market is expected to grow at a compound annual growth rate of 5.97% during the forecast period between 2022 and 2030. Patients in hospitals experience difficulty in getting in and out of their assigned beds due to their condition or health status. Automated hospital beds play a significant role in solving this major problem. These automated beds aid patients to easily sit and get out of their beds with comfort and little to no effort. Add to this, the beds are extremely beneficial for both the doctors and the nurses while performing vital treatments or procedures upon the patients. The global market is influenced by a rising number of chronic and acut

  Market Highlights The assisted reproductive technology (ART) market is expected to witness tremendous growth owing to the rising prevalence of infertility in males as well as females. Other key factors such as the growing obesity among population, rising ovulation disorders, change to sedentary lifestyle, socioeconomic factors like postponement of marriage due to unemployment and others, growing consumption of unhealthy diet, increasing occurrence of polycystic ovarian syndrome (PCOS), and increasing prevalence of breast or ovarian and endometrial cancer, increase in smoking and alcohol consumption are contributing towards the growth.  However, factors such as, lower success rate, the high cost of  Assisted Reproductive Technology Market Size  procedures, expensive treatments, raising ethical issues, chances of birth defects, the risk of prematurity and low birth weight in new-borns and side effects associated with hysterectomy procedures are expected to restrict the market growth du

  Market Overview AR & VR in Healthcare Market is expected to grow at a CAGR of 27.30% during the forecast period. Virtual reality technology benefits both doctors and patients since it allows patients to virtually visit doctors, which is very convenient. This has propelled the growth of the VR market in the healthcare business to a large extent. VR technology is ahead of Augmented Reality due to its expanded capabilities. Virtual reality allows users to immerse themselves in another environment and interact with it in real-time. In contrast, AR produces a visual environment around you but does not allow you to interact with it. New start-ups keen to capitalize on this extensively utilized technology are among the factors fueling the growth of AR & VR in the Healthcare Market. By combining AR and VR technology into new applications and adding new features to existing products, these start-ups are growing their AR and VR application portfolios. Product pricing has been lowered a

  Market Scope Market Research Future (MRFR) studied the global antibiotics market 2021 for the review period till 2030. As per MRFR analysis, the market of antibiotics is likely to register 4.8% CAGR over the analysis period. By 2030, the  antibiotics market  value is expected to touch USD 51,835 Mn by. Drivers and Restrains Impacting Antibiotics Market The surge in cases of bacterial infections is creating the demand for antibiotics that can support the expansion of the market. The increase in cases of COVID 19 and sepsis induced by COVID-19 can boost the demand for high power antibiotics, which, in turn, can prompt the market expansion. The availability of different type of antibiotics, one which can stop bacteria from reproducing and another that can destroy them, across different countries to meet treatment requirements of patient can improve the impetus of the antibiotics market. increasing efforts by major companies for the formulation of advanced antibiotic products, rise in ap

  Market Overview  the allergy immunotherapy market in the global  Allergy Immunotherapy Market  will grow at a higher CAGR of 10.85% by the end of the forecasted period and account for a market share of approximately 4.32 billion by the end of the forecasted period from 2022 to 2027. Market Dynamics The market for medications to treat a variety of disorders is growing as a result of the rising demand. A growing number of allergic ailment pills have been manufactured by major market participants as a result of increased research efforts to meet the market's demand. Because of an increase in personal disposable income, consumers can afford to spend more money on allergy-related therapies, creating an opportunity for the expansion of the allergy immunotherapy market throughout the forecast period. As a result, the global allergy immunotherapy market has grown as a result of rising pollution levels, higher alcohol consumption, and changes in dietary patterns and lifestyles. The global

  Medical Sensors Market – Overview The vast range of needs that can be addressed by  Medical Sensors Market  is growing with each passing day and discovery, leading to a fast-paced development period for this sector. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently published a report on this market. The global market for medical sensors is expected to grow at the rate of approximately 7.6% from 2022 to 2030. Medical sensors have become an integral part of the medical diagnostic sector. Many ailments are being tracked and treated by use of medical sensors. Since most of the medical sensors can provide real time feedback, they are used for treatment in conditions where the health state fluctuates a lot. This is one of the primary reasons that is boosting the growth of the market. Many industry players are already capitalizing on this trend, as the segment is relatively new. Medical sensors also relatively increase

  Rheumatoid arthritis Market Overview: During old age, rheumatoid arthritis problem is common. And smokers are more prone to it. Contrary to popular belief, rheumatoid arthritis goes beyond joint pain. Sometimes, it can also damage various parts of the body system that include blood vessels, eyes, heart, lungs, and skin. Therefore, the rheumatoid arthritis market is growing. Market Research Future (MRFR) has published a research report that predicts success for the global rheumatoid arthritis market with 4% CAGR (Compound Annual Growth Rate) between 2022 and 2030. Analyzing the market structure, this report evaluates the future growth potential and observes the strategies of the key players in this market. It also tracks the competitive developments such as joint ventures, mergers, and acquisitions, new product developments, new product developments (R & D) in the market. According to a study, the women are three times more prone to this disease than men. The key factors that can

  CAR T Cell Therapy Market-Overview Chimeric Antigen Receptor (CAR)-T is a revolutionary treatment that involves reengineering the patient's white blood cells (WBCs) to assist in the fight against cancerous cells by identifying them. The industry is taking steps to address various issues to foster the adoption of CAR-T cell therapy. Several CAR-T players have begun to impregnate T cells with CARs using efficient gene-transfer techniques to treat several conditions. As per MRFR, the market is estimated to utilize a CAGR of 48.96% and reach USD 10,415.61 million by the end of the period in 2027. Over the forecast period, soaring cancer incidences around the world, together with persistent technical advancements for dependable and effective cancer treatment, are likely to support the progress of the worldwide CAR-T cell therapy market. Key Players: The important companies in the CAR T cell therapy market are Intellia Therapeutics (US), Merck KGaA (Germany), Servier Laboratories (Fran

  Market Highlights The global immunoassay market size accounted for USD 18,626.7 million in 2022 and is projected to register a CAGR of 5.9% over the forecast period. Immunoassay is a biochemical test that relies on biochemistry to measure the presence and concentration of an analyte (protein, lipid, nucleic acid, among others) in solution (serum, urine, etc.) by using antibody-antigen reactions. Some of the factors characterizing the market growth are rising R&D expenditure in the healthcare sector, rising prevalence of chronic and infectious diseases, increasing adoption of immunoassay, technological advancements in immunoassay instruments and the introduction of novel automated systems, and surging elderly population across the world. For instance, the World Health Organization (WHO) reported that global elderly population was 841.0 million in 2013, increased to 962.3 million in 2022, which is projected to reach more than 2.0 billion by the end of 2050. In contrast, limitations

  Market Highlights The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. The increasing demand for monoclonal antibodies, increasing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to propel the growth of the market over the assessment period. On the other hand, the lack of skilled professionals is excepted to hinder the market growth during the forecast period. The global desalting and buffer exchange column market is currently governed by a large number of market players. The prominent market players

  Market Scope Market Research Future (MRFR) anticipates the biosurgery market to attain a healthy CAGR around 7.0% from 2022 to 2027 (assessment period). Growth Boosters and Deterrents Major growth boosters in the biosurgery market include the escalating number of surgeries, especially in emerging countries such as Mexico, India, Brazil, and Japan. Soaring number of sports injuries, rising burden of obesity cases, and the surge in spinal issues worldwide have also raised the demand for biosurgeries. With manufacturers increasingly focusing on taking up exhaustive research and development initiatives to create cutting-edge and high performance biosurgery devices, the global market is deemed to witness strong growth in the following years. Moreover, innovations with respect to healthcare technologies and their rapid adoption by the industry should also underpin the market growth during the given period. The global market will get further boost from the expanding elderly population, whic

  Market Overview: With a 12 percent CAGR, the Clinical Decision Support Systems (CDSS) market is estimated to reach USD 1.76 billion by 2030. Clinical decision support systems (CDSS) are an essential component of the healthcare IT spectrum. Breakthrough technological developments encourage CDSS adoption, which enables speedier decision-making, data management, and enhanced workflow competency in inpatient care. The adjustable functions of this system are playing a significant role in boosting  Clinical Decision Support Systems Market  trends. The COVID-19 epidemic has created new hurdles in the healthcare ecosystem. Hospitals and health systems are dealing with massive influxes of critically sick patients as well as personnel shortages and capacity constraints. However, doctors are now better equipped with the information and abilities gained during the pandemic's early stages to develop the ideas. The increased usage of clinical decision support software in COVID-19 has emphasize

  Market Insights: As per Market Research Future (MRFR)’s latest report, the global blood transfusion diagnostics market is set to expand at a CAGR of 8.2% during the forecast period 2017 to 2023. The value of the market is estimated to grow from USD 1.5 Bn in 2016 to USD 2.45 Bn in 2023. The excess demand for blood transfusions over its supply is likely to expedite the growth of the blood transfusion diagnostics market through the projection period. The rising awareness about blood donation coupled with exponentially increasing cases of emergency is likely to intensify the demand for blood transfusion diagnostics for preventing the transfer of infectious diseases. The large-scale prevalence of infectious blood diseases is another major factor responsible for catapulting the blood transfusion diagnostics market on an upward trajectory. The technological advancements and deployment of automation in blood banks are anticipated to have a favorable impact on the proliferation of the blood

  Market Scenario The global wound debridement products market is predicted to register a significant CAGR during the forecast period (2022-2030) owing to the increasing demand for advanced medical facilities, asserts Market Research Future (MRFR). Wound debridement is referred to as a process to eliminate foreign invaders, toxic substances, and dead tissues from human wounds. Wound debridement products help to reduce poisonous materials that prevent the wounds from getting healed. It is the process of removal of contaminated, dead, and unhealthy tissue from a wound in order to promote wound healing. The dead skin restricts the formation of new tissue and hides the signs of infections, which further makes it difficult for treatment. In order to curb all such problems, wound debridement is essential. Competitive Dashboard The prominent players operating the global wound debridement products market are Advanced Medical Solutions Group, MediWound Ltd., ArthoCare Corporation, and Smith &am

  Market Highlights The muscle stimulators use electric current to elicit contraction in muscles or nerves. The electric signal has intensity and frequency which mimics the nerve signal system. The muscle stimulator market is also witnessing high technological development. The manufacturing of medical devices in general and muscle stimulators in particular is also undergoing changes. The latest technological advancements include active research in frequencies and strength of electric current used for muscle stimulation. Increasing miniaturization and portability of the muscle stimulator devices is another development that is driving the growth of the market. Market fragmentation and falling profit margin are significant threats to the market. The rise of low cost manufacturing economies s  FDA approved muscle stimulators  such as China are challenging the high-tech segment. The muscle stimulators market credibility is being challenged by the rise of spurious low-quality products. There